GLICLAZID Mepha retard depotabs 30 mg 120 pce
7680585040030
CH-58504
A10BB09
07.06.2.
Reimbursement limitations:
DIAMICRON
Pris en charge lorsque la metformine ne permet pas un contrôle suffisant de la glycémie.
…
1 / 3
google
Details
- Product number
- 5850401
- CPT
- -
- Packaging group
- 120
- Unit
- Tablette(n)
- Composition
- gliclazidum 30.00 mg, hypromellosum, calcii carbonas, lactosum monohydricum 73.50 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso.
Articles (1)
Gliclazid-Mepha 30 retard, Depotabs
Tabletten
120
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
73.5 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 30.30
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/01/2009
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 58504
- Drug name
- Gliclazid-Mepha 30 retard, Depotabs
- Galenic form
- TABWF
- ATC Code
- A10BB09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 08/07/2008
- Authorization expiration date
- 31/12/9999
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- GLICLAZID Mepha retard depotabs 30 mg 120 pce
- Description (DE)
- GLICLAZID Mepha retard Depotabs 30 mg 120 Stk
- Market launch
- 08/07/2008
- Narcotic (BTM)
- No